SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2886HCV and HIV are fundamentally different; the latter integrates into the host genDewDiligence_on_SI-2/17/2012
2885What are the chances that this could be good for Gilead, if HCV infected patientChris08-2/17/2012
2884Sorry, Wrong Thread.<g>Jibacoa-2/17/2012
2883GILD on pre-market trading, after announcing that patients with Hepatitis C genJibacoa-2/17/2012
2882Valentine's Day massacre...Karo Bio off 2/3rds, as its lead program terminatnigel bates-2/14/2012
2881Chelsea (CHTP) off 28% on release of FDA briefing docs that don't look very tuck-2/13/2012
2880Array (ARRY) off ~16% on a financing, priced at $2.60, which is the current low tuck-2/9/2012
2879ACHN -17% (closed -10%) As previously reported, BofA/Merrill downgraded Achilliotnsaf-2/7/2012
2878Infinity (INFI) off 38% on P2 failure of lead drug -- a hedgehog inhibitor -- intuck-1/27/2012
2877Thanks, I posted too fast.fred hayes-1/26/2012
2876Amphastar did not win the appeal, but rather won a stay of the preliminary injunDewDiligence_on_SI-1/26/2012
2875Looks like Amphastar won the appeal. Big surprise at least to me...fred hayes-1/26/2012
2874mnta over 25 percent, can't find any news...fred hayes-1/26/2012
2873DuRect's (DRRX) other advanced candidate, also for pain, flubs P3, and the stuck-1/5/2012
2872AVEO -15% sell on the newstnsaf-1/3/2012
2871I am certain that a large majority of panel members would vote for a drug therapscaram(o)uche-12/22/2011
2870<i>So should VVUS be punished for ratios that are low, just because they&Ian@SI-12/22/2011
2869There has never been an obesity medication that would be taken long-term. Patienscaram(o)uche-12/22/2011
2868Does this pretty well kill it in terms of ever becoming a tx for chronic obesityIan@SI-12/22/2011
2867VVUS pre-market, on data from FORTRESS that strongly indicates that a component scaram(o)uche-12/22/2011
2866Targacept Inc., (TRGT) developer of an experimental depression treatment with Atnsaf-12/20/2011
2865BioSante (BPAX) off 16% as placebo outperforms LibiGel in P3. Will probably gettuck-12/14/2011
2864Endocyte (ECYT) spluts 63% on failed P2B trial in platinum resistant ovarian cantuck-12/13/2011
2863Now it looks decently priced.. perhaps it is in for a january pop. Cheers!RockyBalboa-12/13/2011
2862Although I did investigate Rexahn about a year ago when another called it a scamBiotech Jim-12/6/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News